JP2006014637A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006014637A5 JP2006014637A5 JP2004194599A JP2004194599A JP2006014637A5 JP 2006014637 A5 JP2006014637 A5 JP 2006014637A5 JP 2004194599 A JP2004194599 A JP 2004194599A JP 2004194599 A JP2004194599 A JP 2004194599A JP 2006014637 A5 JP2006014637 A5 JP 2006014637A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cytotoxic
- peptides
- cytotoxic activity
- clone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 108010013476 HLA-A24 Antigen Proteins 0.000 description 2
- 108010014655 NYGFQIHTK Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004194599A JP4547197B2 (ja) | 2004-06-30 | 2004-06-30 | 癌特異的腫瘍抗原 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004194599A JP4547197B2 (ja) | 2004-06-30 | 2004-06-30 | 癌特異的腫瘍抗原 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006014637A JP2006014637A (ja) | 2006-01-19 |
| JP2006014637A5 true JP2006014637A5 (enExample) | 2007-08-09 |
| JP4547197B2 JP4547197B2 (ja) | 2010-09-22 |
Family
ID=35789422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004194599A Expired - Fee Related JP4547197B2 (ja) | 2004-06-30 | 2004-06-30 | 癌特異的腫瘍抗原 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4547197B2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200932260A (en) * | 2007-11-28 | 2009-08-01 | Oncotherapy Science Inc | STAT3 epitope peptides |
| TW201000119A (en) * | 2008-06-10 | 2010-01-01 | Oncotherapy Science Inc | MYBL2 epitope peptides and vaccines containing the same |
| HUE035804T2 (en) * | 2008-07-10 | 2018-05-28 | Toray Industries | Immunity inducing agent and method for detecting cancer |
| HUE028589T2 (en) | 2008-07-10 | 2016-12-28 | Toray Industries | Pharmaceutical preparation for the treatment and prevention of cancer |
| JP6077641B2 (ja) | 2013-03-08 | 2017-02-08 | 大鵬薬品工業株式会社 | 新規ｃｔｌエピトープ５連結ペプチド |
| AU2014337643B2 (en) | 2013-10-21 | 2017-07-13 | Taiho Pharmaceutical Co., Ltd. | Novel four-CTL epitope-joined peptide |
-
2004
- 2004-06-30 JP JP2004194599A patent/JP4547197B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2570430A3 (en) | Peptide vaccines with Seq ID No: 78, 41, 44, 46 or 48 for cancers expressing tumor-associated antigens | |
| JP2005505579A5 (enExample) | ||
| JP2005516581A5 (enExample) | ||
| JP2009268467A5 (enExample) | ||
| JP2010065037A5 (enExample) | ||
| JP2013521789A5 (enExample) | ||
| PT1761553E (pt) | Peptídeos associados a tumores de ligação à molécula mhc | |
| MY204458A (en) | Tertiary amino lipidated cationic peptides for nucleic acid delivery | |
| TWI455946B (zh) | 抗磷脂醯肌醇蛋白聚糖３抗體 | |
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| JP2007508034A5 (enExample) | ||
| JP2012505657A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| ATE355259T1 (de) | Radiofluorierungsverfahren | |
| JP2006014637A5 (enExample) | ||
| EP2481748A3 (en) | Foxp3 peptide vaccine | |
| JP2013523084A5 (enExample) | ||
| MX2010005816A (es) | Epítopos de péptido de stat3. | |
| JP2006503088A5 (enExample) | ||
| JP2019038772A5 (enExample) | ||
| JP2006022119A5 (enExample) | ||
| RU2008153051A (ru) | Способ направленной доставки днк в опухолевые и стволовые клетки | |
| JP2008526698A5 (enExample) | ||
| RU2002110800A (ru) | Искусственный белок-иммуноген TCI, содержащий множественные CTL-эпитопы основных антигенов ВИЧ-1, искусственный ген TCI, кодирующий полиэпитопный белок-иммуноген TCI | |
| JP2006525223A5 (enExample) |